Platelet-Inspired Nanotherapeutics for Biomedical Applications
Source abstract
Abstract
Platelets, as abundant corpuscles in the blood, are extensively involved in normal physiological processes and disease occurrence. Recently, remarkable progress in platelet-based nanotherapeutics has been made, especially with the burgeoning fields of biotechnology and nanomedicine. Herein, we aim to provide an overview on platelet-inspired nanotherapeutics for biomedical applications. First, the recent trends of biomimetic platelet-inspired nanotherapeutics are outlined, mainly including platelet membrane-camouflaged nanosystems, platelets loading with nanoparticles and platelet-mimicking nanocarriers. Then, the emerging nanotherapeutics for functional modulation of platelet aggregation, activation, and inhibition are discussed. Subsequently, platelet derivative-based nanotherapeutics are presented, including platelet extracellular vesicles and platelet polyphosphates. Finally, the clinical application prospects of these emerging nanotherapeutics are highlighted, with particular emphasis on their rationale, advantages, and challenges.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Platelet Disorders and Treatments · Extracellular vesicles in disease · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang 110016, PR China
Department of Pharmaceutical Analysis, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, PR China
Funding
Liaoning Revitalization Talents Program · China Postdoctoral Science Foundation · Natural Science Foundation of Liaoning Province · Excellent Youth Science Foundation of Liaoning Province
References (100+)
Show source-provided references
1. 10.1182/blood.202000721410.1182/blood.2020007214 ↗
2. 10.1016/j.copbio.2018.11.01010.1016/j.copbio.2018.11.010 ↗
3. 10.1126/scirobotics.aba613710.1126/scirobotics.aba6137 ↗
4. 10.3324/haematol.2020.27079310.3324/haematol.2020.270793 ↗
5. 10.1038/s41419-020-03333-910.1038/s41419-020-03333-9 ↗
6. 10.1002/adhm.20210162810.1002/adhm.202101628 ↗
7. 10.1016/j.jconrel.2022.04.04610.1016/j.jconrel.2022.04.046 ↗
8. 10.3390/cells1011303410.3390/cells10113034 ↗
9. 10.1016/j.biomaterials.2019.11926710.1016/j.biomaterials.2019.119267 ↗
10. 10.1021/acsnano.1c0420610.1021/acsnano.1c04206 ↗
11. 10.1016/j.trecan.2020.05.00110.1016/j.trecan.2020.05.001 ↗
12. 10.1182/bloodadvances.201802437210.1182/bloodadvances.2018024372 ↗
13. 10.1111/jth.1441910.1111/jth.14419 ↗
14. 10.1161/ATVBAHA.119.31369810.1161/ATVBAHA.119.313698 ↗
15. 10.1038/s41584-019-0187-910.1038/s41584-019-0187-9 ↗
16. 10.3390/jcm1005089410.3390/jcm10050894 ↗
17. 10.1002/EXP.2021001110.1002/EXP.20210011 ↗
18. 10.1021/acsmaterialslett.2c0052810.1021/acsmaterialslett.2c00528 ↗
19. 10.1021/acsmaterialslett.0c0007810.1021/acsmaterialslett.0c00078 ↗
20. 10.1016/j.cclet.2021.11.05610.1016/j.cclet.2021.11.056 ↗
21. 10.1002/EXP.2021001010.1002/EXP.20210010 ↗
22. 10.1016/j.cej.2021.13083810.1016/j.cej.2021.130838 ↗
23. 10.1016/j.apsb.2021.02.00110.1016/j.apsb.2021.02.001 ↗
24. 10.1016/j.jconrel.2020.07.03610.1016/j.jconrel.2020.07.036 ↗
25. 10.1016/j.nantod.2018.11.00210.1016/j.nantod.2018.11.002 ↗
26. 10.1021/acs.molpharmaceut.0c0042110.1021/acs.molpharmaceut.0c00421 ↗
27. 10.1016/j.apsb.2021.05.00210.1016/j.apsb.2021.05.002 ↗
28. 10.1002/EXP.2021016610.1002/EXP.20210166 ↗
29. 10.1038/s41565-020-00810-210.1038/s41565-020-00810-2 ↗
30. 10.1016/j.bioactmat.2021.02.03710.1016/j.bioactmat.2021.02.037 ↗
31. 10.1016/j.ajps.2019.11.00410.1016/j.ajps.2019.11.004 ↗
32. 10.1002/EXP.2021009310.1002/EXP.20210093 ↗
33. 10.1016/j.ajps.2019.08.00110.1016/j.ajps.2019.08.001 ↗
34. 10.1016/j.cclet.2019.10.04010.1016/j.cclet.2019.10.040 ↗
35. 10.34133/2022/984545910.34133/2022/9845459 ↗
36. 10.15171/apb.2019.00510.15171/apb.2019.005 ↗
37. 10.1182/blood-2018-06-85552810.1182/blood-2018-06-855528 ↗
38. 10.1182/bloodadvances.202200698010.1182/bloodadvances.2022006980 ↗
39. 10.1021/acsmaterialslett.2c0060110.1021/acsmaterialslett.2c00601 ↗
40. 10.1111/ijlh.1351610.1111/ijlh.13516 ↗
41. 10.1002/smll.20180410510.1002/smll.201804105 ↗
42. 10.1136/annrheumdis-2020-21701310.1136/annrheumdis-2020-217013 ↗
43. 10.7759/cureus.584910.7759/cureus.5849 ↗
44. 10.1080/20009666.2019.156588410.1080/20009666.2019.1565884 ↗
45. 10.3390/cells1012338610.3390/cells10123386 ↗
46. 10.1016/j.amsu.2021.10316410.1016/j.amsu.2021.103164 ↗
47. 10.1016/j.biomaterials.2016.10.00310.1016/j.biomaterials.2016.10.003 ↗
48. 10.1016/j.cclet.2021.10.05510.1016/j.cclet.2021.10.055 ↗
49. 10.1021/acsnano.7b0772010.1021/acsnano.7b07720 ↗
50. 10.1089/dna.2019.509710.1089/dna.2019.5097 ↗
51. 10.1002/adfm.20180356710.1002/adfm.201803567 ↗
52. 10.1038/s41551-017-0182-x10.1038/s41551-017-0182-x ↗
53. 10.1016/j.ejpb.2022.01.00410.1016/j.ejpb.2022.01.004 ↗
54. 10.1182/blood.201900043710.1182/blood.2019000437 ↗
55. 10.1002/sstr.20200001810.1002/sstr.202000018 ↗
56. 10.1038/nature1537310.1038/nature15373 ↗
57. 10.1002/adma.20170480010.1002/adma.201704800 ↗
58. 10.1126/scirobotics.aat048510.1126/scirobotics.aat0485 ↗
59. 10.1021/acs.nanolett.1c0016810.1021/acs.nanolett.1c00168 ↗
60. 10.1039/D0TB00735H10.1039/D0TB00735H ↗
61. 10.1016/j.biomaterials.2017.12.02810.1016/j.biomaterials.2017.12.028 ↗
62. 10.1002/adfm.20160477410.1002/adfm.201604774 ↗
63. 10.1016/j.actbio.2018.09.01710.1016/j.actbio.2018.09.017 ↗
64. 10.1016/j.jconrel.2021.08.02010.1016/j.jconrel.2021.08.020 ↗
65. 10.1016/j.biomaterials.2019.03.02410.1016/j.biomaterials.2019.03.024 ↗
66. 10.1002/adfm.20190344110.1002/adfm.201903441 ↗
67. 10.1021/acsami.1c0258110.1021/acsami.1c02581 ↗
68. 10.1016/j.ajps.2021.03.00110.1016/j.ajps.2021.03.001 ↗
69. 10.1016/j.ajps.2022.02.00410.1016/j.ajps.2022.02.004 ↗
70. 10.1016/j.cclet.2022.05.03210.1016/j.cclet.2022.05.032 ↗
71. 10.1016/j.ijpharm.2021.12039510.1016/j.ijpharm.2021.120395 ↗
72. 10.1007/s12274-018-2126-510.1007/s12274-018-2126-5 ↗
73. 10.18632/oncotarget.851710.18632/oncotarget.8517 ↗
74. 10.1002/EXP.2021014910.1002/EXP.20210149 ↗
75. 10.7150/thno.5906510.7150/thno.59065 ↗
76. 10.1016/j.cclet.2022.01.08610.1016/j.cclet.2022.01.086 ↗
77. 10.1111/jth.1502010.1111/jth.15020 ↗
78. 10.1186/s12929-020-00633-210.1186/s12929-020-00633-2 ↗
79. 10.1021/acsnano.0c0654110.1021/acsnano.0c06541 ↗
80. 10.1039/D0SC01949F10.1039/D0SC01949F ↗
81. 10.7150/thno.3994410.7150/thno.39944 ↗
82. 10.1016/j.cej.2022.13638310.1016/j.cej.2022.136383 ↗
83. 10.1002/ange.20170945710.1002/ange.201709457 ↗
84. 10.1016/j.ajps.2021.10.00110.1016/j.ajps.2021.10.001 ↗
85. 10.1080/09537104.2018.151410910.1080/09537104.2018.1514109 ↗
86. 10.1021/nn503732m10.1021/nn503732m ↗
87. 10.1002/smll.20140153010.1002/smll.201401530 ↗
88. 10.1016/j.biomaterials.2012.09.07410.1016/j.biomaterials.2012.09.074 ↗
89. 10.1126/sciadv.aaz410710.1126/sciadv.aaz4107 ↗
90. Mattsson J. · 2020 · 12910.1201/9780429283024-7 ↗
91. 10.1002/smll.20190106510.1002/smll.201901065 ↗
92. 10.1038/s41598-021-97212-810.1038/s41598-021-97212-8 ↗
93. 10.1126/scitranslmed.abb897510.1126/scitranslmed.abb8975 ↗
94. 10.1080/09537104.2021.196791610.1080/09537104.2021.1967916 ↗
95. 10.1016/j.cej.2021.13062110.1016/j.cej.2021.130621 ↗
96. 10.1007/s10570-019-02795-110.1007/s10570-019-02795-1 ↗
97. 10.1016/j.cej.2021.13435710.1016/j.cej.2021.134357 ↗
98. 10.1016/j.blre.2004.05.00210.1016/j.blre.2004.05.002 ↗
99. 10.1177/216507992093073010.1177/2165079920930730 ↗
100. 10.1002/emp2.1272510.1002/emp2.12725 ↗